Trial Profile

A first in human clinical trial of SPC-15

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 07 Jan 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs SPC 15 (Primary)
Indications Anxiety disorders; Post-traumatic stress disorders
Focus Adverse reactions; First in man

Most Recent Events

02 Jan 2025 According to a Silo Pharma media release, IND submission expected in 2025.
10 Sep 2024 According to a Silo Pharma media release, a pre-Investigational New Drug (pre-IND) meeting with the U.S. Food and Drug Administration regarding the development plan for SPC-15, an intranasal prophylactic treatment for (PTSD) and stress-induced anxiety disorder has been completed.
22 Jul 2024 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com